20/09/2017
Lonza Introduces the New CytoSMART™ 2
System for Live Cell Imaging
read
more>>
Recipharm to make clinical trial cancer
candidate for Kancera read
mroe>>
FDA's Janet Woodcock: the clinical trials system
is 'broken' read
more>>
Sanofi tests three-in-one antibody to treat or prevent
HIV read
more>>
Shire, Shionogi's ADHD drug for adults clears late-stage
trial in Japan read more>>
GSK gets FDA approval for key triple therapy
inhaler read
more>>
19/09/2017
AbbVie and Roche plan Venclexta combo
filings in leukaemia
read
more>>
Teva sells women's health division to tackle
$35bn debts read
more>>
Planning teams forming as Thermo Fisher completes
$7.2bn Patheon acquisition read
more>>
New lab space to support CRO’s acceleration into 2018
read
more>>
FDA approves Trelegy Ellipta inhaler for GlaxoSmithKline,
Innoviva read
more>>
18/09/2017
Bayer’s rare
cancer drug Aliqopa bags speedy approval read
more>>
NICE rejects
first-line use of Roche’s Gazyvaro
read
more>>
Immunocore and Bill and
Melinda Gates Foundation collaboration read
more>>
Novartis' Xolair shows strong
retreatment efficacy at Phase 3 in chronic spontaneous
urticaria read
more>>
15/09/2017
QuintilesIMS
Announces Launch of Secondary Public Offering and Repurchase of
Common Stock
read
more>>
FDA clears first-ever medical app that helps kick drug addiction read more>>
FDA approves first-ever
biosimilar for cancer treatment read
more>>
Novo highlights key ‘hypo’ data
from Tresiba at EASD read
more>>
14/09/2017
Evotec and
MaRS Innovation establish Academic Bridge "LAB150" in
Toronto
read
more>>
Pfizer, Astellas
prostate cancer drug promising in late-stage trial read
more>>
GSK lines
up a shot at a blockbuster market as new CEO prepares to tackle
Merck rival head on read
more>>
Pfizer boosts
Ibrance's class with positive neutropenia data
read
more>>
AstraZeneca’s Forxiga
displays potential in type 1 diabetes read
more>>
Alexion to Restructure
Operations, to Lower Headcount by 20% read
more>>
Roche (RHHBY) Announces Data on
Respiratory Drug Esbriet
read
more>>
13/09/2017
Alexion's Headquarters Relocation Stings In New Haven read more>>
Scott Gottlieb is closing a big loophole in the orphan drug law read more>>
FDA grants fast-track designation
for Shire's lung drug
read
more>>
12/09/2017
Roche under
pressure as second rituximab biosimilar filed in US read
more>>
Alexion preps big
layoffs and a move to Boston/Cambridge read
more>>
Shire gets US FDA fast
track designation for lung disease drug read
more>>
Novartis says biosimilar
rituximab accepted for review by FDA
read more>>
11/09/2017
PAREXEL
Launches Real-World Data Service Offering to Drive Value
Demonstration of New Treatments
read
more>>
Lonza
Consumer Care Launches Online "Survive the BPR™" Knowledge
Centre
read
more>>
Merck's
Keytruda extends survival edge on its bladder cancer
rivals read
more>>
GSK
exercises global licence option for Adaptimmune’s NY-ESO-1 T-cell
therapy read
more>>
AstraZeneca lung cancer
trial results impress but risks remain, analysts say read
more>>
Teva appoints
Lundbeck’s Kare Schultz as CEO read
more>>
Regeneron and Sanofi receive FDA’s breakthrough therapy status for CSCC treatment with cemiplimab read more>>
Catalent to make opioid
withdrawal candidate for US approval read
more>>
Sanofi and Regeneron announce
positive dupilumab topline results read
more>>
24/08/2017
Lonza to
Increase and Expand Capabilities for Drug Product Services for
Parenteral Dosage Forms
read
more>>
Digital-minded
Novartis taps Apple's ResearchKit for smartphone MS study
read
more>>
Novartis receives EU
approval for breast cancer drug Kisqali read
more>>
Roche says FDA grants
priority review to hemophilia drug emicizumab read
more>>
AstraZeneca drug reduces risk of
repeat heart attack by almost a third read
more>>
23/08/2017
GVK BIO
RECEIVES BEST LIFE SCIENCES QHSE LEADERSHIP INDIA 2017
read
more>>
GlaxoSmithKline
partners with Alibaba for China HPV vaccine market grab
read
more>>
NICE rejects thyroid
cancer drugs
read
more>>
India grants Pfizer patent
on pneumonia vaccine in blow to aid group read
more>>
Envigo eyes public market capital
in Avista merger read
more>>
22/08/2017
Jubilant receives
NDA approval for Drax Exametazime read
more>>
PAREXEL
and Osaka International Cancer Institute Form Alliance to Advance
Clinical Research in Japan read
more>>
AstraZeneca
strikes mRNA-based partnership in respiratory disease
read
more>>
Novartis launches MS
smartphone trial
read
more>>
$417 Million Awarded in
Suit Tying Johnson’s Baby Powder to Cancer read
more>>
Orphan drugs: overcoming barriers
to market access read
more>>
17/08/2017
Inaugural
Charles River World Congress on Animal Models in Drug Discovery
& Development to Explore Trends in Reverse Translational
Medicine read
more>>
AZ looks to
pay-for-performance to bolster cardio-diabetes franchise read
more>>
BASF outlines plans for
$50m Mumbai R&D campus read
more>>
Evotec completes Aptuit
acquisition read
more>>
16/08/2017
After a slow start,
Novartis finally gains market traction with heart drug
Entresto
read
more>>
Sanofi and Regeneron end
ten-year mAb collaboration read
more>>
FDA grants orphan drug status to H3 Biomedicine’s cancer treatment read more>>
14/08/2017
Mylan
launches three generic anti-retroviral treatments for HIV patients
in Canada read
more>>
NICE expands
Merck KGaA’s Erbitux reach read
more>>
GSK walks away from
Ionis antisense drugs read
more>>
NICE turns down kidney
cancer drugs
read
more>>
Oxford BioMedica enters Innovate
UK-backed agreement read
more>>
10/08/2017 &nb
© 2017 The World of CROs. All rights reserved.
Related links:
First COPD patient treated with RejuvenAir System in a multicenter clinical trial bit.ly/3m1YDPC
21st October @ 07:28Brain imaging biomarker may help predict treatment response in patients with psychiatric disorders, study reveals bit.ly/34hhHni
21st October @ 07:27Here's how Bristol Myers' CEO Giovanni Caforio completed a $13B buyout: He moved fast, upped the bid quickly and de… twitter.com/i/web/status/1…
21st October @ 07:25